Top White House scientist resigns after review finds he demeaned staff
By Tyler Pager,
The Washington Post
| 02. 07. 2022
"Keynote speaker Eric Lander 1" by afagen
is licensed under CC BY-SA 2.0
Eric Lander, President Biden’s top science adviser, resigned Monday night after he acknowledged mistreating his subordinates and apologized for demeaning them, a pattern of behavior that put him at odds with one of Biden’s earliest promises — to run an administration marked by respect and professionalism.
An internal review by the White House found credible evidence that Lander, director of the Office of Science and Technology Policy, bullied staff in violation of the White House’s “safe and respectful workplace policy,” which was intended in part to draw a contrast with the Trump administration.
Lander’s resignation came after the White House struggled throughout the day to explain why he had not quit or been fired, and how that squared with a pledge Biden made on his first day in office. On that day, he told staffers at swearing-in ceremony, “If you are ever working with me and I hear you treat another colleague with disrespect, talk down to someone, I promise you I will fire you on...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...